Fasken advised Danaher Corporation ("Danaher") on its acquisition of General Electric’s biopharmaceutical business, GE Biopharma, for a cash purchase price of approximately $21.4 billion.
Fasken supported the DLA Piper team advising Danaher Corporation on English law real estate, share purchase and business transfer agreements and overseeing the completion of such documents in a number of jurisdictions worldwide.
Click here for further information.
A Fasken team composed of Guy Winter and Laura Bradley advised Danaher Corporation in connection with this acquisition.
